ArticleAlimentary pharmacology & therapeutics2022
Editorial: intravenous to subcutaneous vedolizumab-switch without glitch! Authors' reply.
Viktoria Bergqvist et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it